Bovine rotavirus (BRV) V 1005 was characterized by two-way crossneutralization tests as a second serotype of BRV. Virions and inner shell particles of 65 nm and 55 nm diameter respectively, and empty capsids of 65 nm and 55 nm diameter were separated by density gradient centrifugation. Three polypeptides of molecular weight 60,000, 36,000 and 28,000 (minor protein) could be identified in the outer shell of virions and in the larger empty capsids. Inner shell particles contained three polypeptides of molecular weight 105,000, 83,000 and 43,000. Both sizes of empty eapsids showed two polypeptides of molecular weight 75,000 and 55,000 not found in virions. Pulse-labelling of infected cells revealed eight major and three minor intracellular viral polypeptides. Viral polypeptide synthesis started at about 6 hours p.i. and correlated in time with double-stranded RNA synthesis. As soon as viral polypeptide synthesis was detectable, newly synthesized virM polypeptides were incorporated into intracellular viral partieles. Radioactive viral polypeptides appeared without a longer lag period in extraeellular viruses from 6 hours p.i. onwards.
Introduction
Rotaviruses are a major cause of acute viral diarrhoea in a number of mammalian and avian species (9, 25) . Several serotypes have been identified among rotaviruses ti:om children (2, 36) , calves (5, 16, 27, 30, 33, 35) , foals (13) , piglets (3), mice (12) and avian species (26) . In calves about 90 per cent of rotavirus isolates belong to one serotype represented by bovine rotavirus (BI~V) UK (33, 35) . [[~vo other serotypes of BRV have been described (5, 16, 27, 30, 33, 35) . Prototype 1 BRV UK has been well characterized (6, 21, 23, 24, 28, 34) , but detailed information about other serotypes of BRV is scarce (31) . In this report we give a biochemical description of the extracellular viral particles of BRV V 1005, which belongs to a second serotype of Bt~V, and its replication cycle in MA-104 cells.
Materials and Methods

Vi~tse8
BRV UK, BRV NCDV, BRV V 1005 and simian rotavirus SA-11 were obtained from Prof. Bachmann (Institute of Medical Microbiology, Infectious and Epidemic Diseases, Veterinary Faculty,, University of Munich, Federal Republic Germany). Bt~V V 1005 was isolated in his laboratory (1) .
Tissue Culture
MA-104 cells were grown in 840 cm 2 disposable glass roller bottles (Flow laboratories) in minimal essential medium containing 10 per cent foetal bovine serum and maintained after inoculation in medium 199 containing 10 per cent tryptose phosphate and 10 ~g/ml porcine pancreatic trypsin (Flow laboratories cat. No. 16--893) . BRV V 1005 was treated with 20 ~g/ml of trypsin at 37 ° C for 30 minutes before inoculation. Cells were inoculated at a multiplicity of infection of 4 TCIDs0 per cell. Infectivity titrations were done according to BACH~IA~N and HEss (t).
Extracellular Rotavirus Purification and Electron Microscopy
Extracellular rotavirus particles were recovered from the cell-free culture supernatant of infected cells by high-speed centrifugation (90,000 × g, 2 hours, 4 ° C) through a 20 per cent sucrose cushion. They were further purified by CsC1 equilibrium centrifugation (SB-405 rotor, International, 180,000 × g, 18 hours, initial density p = 1388 g/ml). The viral particles banding at the different density positions were recovered with a pasteur pipette, diluted with 0.9 per cent NaC1 containing 10 mM CaC12 and pelleted by a further high-speed centrifugation (130,000 x g, 1 hour, 4 ° C). Alternatively, viruses were pelleted after dilution with 0.9 per cent NaC1 containing 10 mM EDTA. The viral particles were deposited on copper grids coated with a formvar film and carbon. They were negatively stained with a 2 per cent solution of phosphotungstic acid, pH 7.0. Particles were viewed with a Phitips EM 300 electron microscope at 80 kV accelerating voltage.
Radioactive Labelling and Isolation of Intracellular Viral Particles
The cells were labelled at 1-5, 5-9, 9-13 and 13-17 hours post infection (p.i.) with ~5S-methionine (7 ~Ci/ml, > 800 Ci/mmol, New England Nuclear) in methionine~free MEM containing 5 ~g/ml trypsin. Alternatively, the cells were labelled at t/he same time intervMs with aH-uridine (7 ~Ci/ml, 80 Ci/mmol, Amersham). Immediately after the labelling period, the cells of one roller bottle were scraped off, washed in ice-cold PBS and resuspended in 50 mM Tris-HC1, pH 7.5, containing 150 ram NaC1, 10 m~ CaC12, 5 ~g/ml soybean trypsin inhibitor (Sigma) and 0.5 per cent of the nonionie detergent Nonidet-P/40. The cellular extract was fractionated by differential centrifugation. Low-speed centrifugation (800 × g, 5 minutes, + 4 ° C) was tbllowed by medium-speed centrifugation (10,000 × g, 30 minutes, + 4°C) and finally by high-speed centrifugation (130,000 × g, 1 hour, + 4 ° C). The high-speed pellet was checked by electron microscopy after negative staining. 90 per cent of the material consisted of rotaviral particles. Some small membrane-derived debris was also found in this fraction.
For the comparison of intracellular viral proteins of different rotavirus strains, the infection medium was replaced at 12 hours p. i. with 20 ml methionine-free MEM to which 5 ~Ci/ml of 3~S-methionine (Amersham Ltd.) was added. After one hour labelling, cells were scraped from the roller surface with a rubber policeman. The cells were washed in phosphate buffered saline and tysed in the gel electrophoresis sample buffer (20) .
Gel Electrophoresis
Protein electrophoresis was carried out in slab gels by Laemmti's method (20) using 13 per cent running and 3 per cent stacking gels. Molecular weights were calibrated using a mixture of 14C-methylated polypeptides (Amersham), gels were fluorographed with Englightning (New England Nuclear), dried and exposed on X-ray films (Y AR-5, Kodak).
Hyperimmunization of Mice and Guinea Pigs
Purified viral particles [approximately 50 ~g proteins as determined by the method of BI~ADFORD (4) for each injection] were homogenized in Freund's complete adjuvant (first injection), in Freund's incomplete adjuvant (second injection), and in phosphate buffered saline (third injection). The viruses were administered intraperitoneally into mice and intramuscularly into guinea pigs. Animals were previously shown to be free of neutralizing antibodies to BRV UK, V 1005 and simian rotavirus SA-11. Sera were analysed 20 days after the last injection for neutralizing activity against 100 TCIDs0 of BI~V UK, BI~V V 1005 and simian rotavirus SA-11 with the immunoperoxidase microtiter neutralization test of GERNA et al. (11) . NT-titers are expressed as the reciprocal of the serum dilution reducing the number of infected cells by 90 per cent.
Column Chromatography
The cells were labelled with 3H-uridine in the presence of 2 ~g/ml actinomycin D (Serva). Cells were lysed for 1 hour at 37°C in I m] TNE-buffer (50 mM Tris-HC1, pH 6.9; 1 mIv~ EDTA, 100 mM NaC1) containing 0.8 per cent SDS (Sigma) and 500 ~g/mt proteinase K (Merck).
After three phenol extractions the l~NA was precipitated with ethanol (overnight, -2 0 ° C). Cellulose column chromatography was performed as described by FRANKLIN (10). Each 1 ml fraction was counted in i0 ml Aquasol (NEN) in a liquid scintillation counter (Mark III, Searle).
Results
Neutralization Test
N e u t r a l~a t i o n tests with h y~e r i m m u n e g u i n e a pig a n d m o u s e s e r a s h o w e d t h a t b o v i n e r o t a v i r u s V 1005 w a s serologieMly distinct f r o m bovine r o t a v i r u s U K , a p r o t o t y p e bovine r o t a v i r u s strain (Table 1) . M o r e t h a n t w e n t y times t h e limiting c o n c e n t r a t i o n o f a n t i s e r a w h i c h n e u t r a l i z e d 100 TCIDso o f B R V U K failed to neutralize 100 TCIDs0 o f B R V V 1005 a n d m o r e t h a n 20 a n t i b o d y units o f sera to B R V V 1005 failed to neutralize 100 TCID~0 o f B R V U K . B R V V 1005 is serologically as different f r o m p r o t o t y p e B R V U K as is for e x a m p l e s i m i a n r o t a v i i~s SA-11. N o significant serological i n t e r r e l a t i o n s h i p w a s d e t e c t e d b e t w e e n bovine r o t a v i r u s V 1005 a n d h u m a n 
Four Particle Types of Extracellular Rotavirus
Extracellular BRV V 1005 grown in MAd04 cells was analyzed by CsC1 density gradient centrifhgation. Centrifugation resulted in the formation of four bands at buoyant densities of 1.31, 1.315, 1.36 and 1.38 g/ml. By electron microscopy the band at 1.31 g/ml was found to contain inner shell empty capsids of 55 nm diameter (Fig. 1 a) . The band at 1.315 g/ml showed larger (65 nm) and less organized empty eapsids (Fig. t b) . The band at 1.36 g/ml contained 65 nm virions (Fig. I c) and the band at 1.38 g/rot gave 55 nm inner shell particles (Fig. i d) . In a typical experiment 90 per cent of the infectivity applied to the gradient was associated with 65 nm virions; inner shell particles showed much lower infectivities and empty eapsids were essentially non-infectious (e.g. 10~.sTCIDs0 at p = l . 3 6 g / m l versus 105TCID~0 at p = 1.38 g/ml and 102TCIDso at p = 1.31 g/ml).
Polypeptide Composition of Extracellular Rotavirus
The four particle types separated by CsC1 density gradients were analysed by SDS-polyaerylamide gel eleetrophoresis (Fig. 2) . Virions are composed of 6 polypeptides: four major polypeptides of molecular weight 83,000, 60,000, 43,000 and 36,000, one minor pol~29eptide of molecular weight 105,000 and a very weakly labelled protein of molecular weight 28,000 (Fig. 2, lane e) . In comparison with virions, inner shell particles lack the polypeptides of molecular weight 60,000, 36,000 and 28,000 (Fig. 2,  lane d) . The two types of empty eapsids contain two polypeptides of molecular weight 75,000 and 55,000 (Fig. 2, lanes a, b) which are not found (Fig. 2, lanes B, e) or inner shell particles (Fig. 2, lanes a, d) . Treatment of purified virions of BRV 1005 with EDTA removed the viral potypeptides of molecular weight 60,000 and 36,000 (Fig. 3) , transforming the virions into inner shell particles (see also 7, 23).
Viral Protein Synthesis in Infected Cells
BRV V 1005 induced the synthesis in infected MA-104 cells of polypeptides with molecular weights [minor polypeptides in parenthesis, VI= nomenclature according to (23) ] 105,000 (VP 1), 83,000 (VP 2), (80,000) (VP3), 75,000 (VP4), (55,000) (VP5), 43,000 (VP6), 36,000 (VP7), 35,000 (VP 8), (34,000) (VP 9), 28,000 (VP 10), (20,000) (VP 11) (Fig. 4, lane  b; Fig. 5 B, lanes d and e) which were not found in uninfected cells (Fig. 5 b,  lane a) . Intraceltular polypeptides induced by BRV V 1005 were compared to those induced by BI~V Ulx, BgV NCDV and simian rotavirus SA-11 (Fig. 4, lanes a to d) . Slight molecular weight differences were observed for polypeptides with molecular weights 34,000 to 36,000. V P l l was consistently barely detectable in V 1005 infected cells. 
Time Course of Rotavirus V1005 Reptication in MA-104 Cells
W h e n M A d 0 4 cells w e r e i n f e c t e d w i t h b o v i n e r o t a v i r u s V 1005 a t a m u l t i p l i c i t y of 4 TCID~0
/cell, i n f e c t i o u s p r o g e n y v i r u s a p p e a r e d in t h e s u p e rn a t a n t 5 h o u r s p.i. a n d i n c r e a s e d e x p o n e n t i M l y for u p to 17 h o u r s p.i. B e f o r e cell d e t a c h m e n t , h i g h e r i n t r a c e l l u l a r t h~n e x t r a e e l l u l a r t i t e r s of i n f e c t i o u s virus were found (Fig. 5, A) . With cell detachment at 30 hours p.i. the majority of intraeellutar virus was released into the medium.
The time periods when labelling experiments were performed with 3~S-methionine or 3H-uridine to correlate data on nucleic acid and protein synthesis in bovine rotavirus-infected cells with viral particle synthesis, are shown as L1 to L 4 in Fig. 5, A .
In the first labelling period (L 1:1-5 hours p.i.) intracellular polypeptide synthesis was indistinguishable from unintbcted cells (Fig. 5 B, lanes a and  b) . In the second and third labelling period (L 2: 5-9, L 3 : 9 -1 3 hours p.i.) viral polypeptide synthesis was evident on a background of cellular protein synthesis (Fig. 5 B, lanes c and d) . With the onset of cytopathic effects (13 hours p.i.) exclusively viral polypeptides were synthesized (L 4 period: 13-17 hours p.i.) (Fig. 5 B, lane e) . Traces of double-stranded RNA were detected in the first labelling period (Fig. 5 (J, lane b) . Double-stranded RNA synthesis was clearly evident in the L 2 period (Fig. 5 C, lane c) , it increased within the L 3 labelling period to remain stationary thereafter (Fig. 5 C,  lanes d and e) . The apparent molecular weight of the viral polypeptides are indicated in thousands (/~) (0.1~g/ml, 0.1 M NaC1, 37°C, 1 hour), whereas t~actions 33-38 were resistant (data not shown).
Neither extracellular nor intracellular viral particles were synthesized in the first labelling period (Fig. 6 A, B, lane b respectively) . From the second labelling period onwards newly synthesized intracellular and extracellular particles were detected (Fig. 6 A, B, lane c respectively) to reach maximal levels in the fourth labelling period.
Discussion
According to the criteria developed for serotype distinction of ECHOviruses (8), rhinoviruses (18) and rotaviruses (36) , bovine rotavirus V 1005 can be attributed to a second BRV serotype. It is serologically different from prototype BRV UK [serotype 6 according to (14) ] and four human rotavirus serotypes [serotype 1-4 according to (14) ]. Actually we do not know whether rotavirus V 1005 resembles serotype 5 (porcine rotavirus OSU, equine rotavirus H-l) or avian serot3~e 7 rotavirus defined by Hosm•o et al. (14) or whether it represents still another rotavirus serotype. In view of serologically distinct and still not classified rabbit (32) and mouse (12) rotaviruses, the number of rotavirus serotypes in mammalian species may be reasonably greater than the 6 serotypes defined by HOSHINO (14) .
The outer shell proteins are the most relevant for the serological distinction of BI~V (17, 19, 22, 29, 31) . Of the three polypeptides identified in the outer shell of BRV 1005 that of molecular weight 36,000 and corresponding to VP 7 (23) is the major protein, followed by a polypeptide of molecular weight 60,000. The polypeptide of 28,000 molecular weight is only a minor component. A similar polypeptide composition was reported for the outer shell of BI~V UK (34) and BRV NCDV (22) . Some authors have described a further outer shell protein of BRV with molecular weight similar to that of VP 7 (6, 19, 21) , whilst others have attributed this protein to the inner shell (23). Novo et al. (28) and McCRAE and FAULKNER-VALLE (23) described a VP 4 protein as a prominent outer shell constituent. We have found this polypeptide only in empty capsids of BRV V 1005, and not in virions. The outer shell polypeptide of molecular weight 60,000 is not a primary gene product of BRV V 1005, because no homologous viral protein is found intracellularly. Therefore it probably represents the major tryptie cleavage product of VP 4, with the minor outer shell protein of molecular weight 28,000 found in V 1005 virions as the minor cleavage product (6) .
The major tryptie cleavage product ofrotavirus hemogglutinin was in the past referred to as VP 5 (6, 21, 22) . However, the fifth gene of BRV UK codes for a VP 5 polypeptide which is only weakly labelled in cells (24) . MCCRAE and McCoRQUODALE (24) described this VP 5 as a non-structural polypeptide because it was not found in inner shell particles and virions.
Actually we detected in empty capsids, but not in inner shell particles or virions a polypeptide with the molecular weight of VP 5 (55,000 in our gel system). Further work must define the identity of this empty capsid-specific polypeptide.
The following conclusions can be drawn from the biochemicM anMysis of the replication cycle of V 1005 rotavirus in/vIA-104 cells. First, we found that viral polypeptide synthesis was correlated in time with viral doublestranded lZNA synthesis. Second, a distinction of early and late synthesis products was not evident for intraeellular V 1005 potypeptide synthesis, genomic I~NA synthesis and intracellular and extracellular viral particles. Third, as soon as viral polypeptide synthesis was differentiable from the background of host protein synthesis, newly synthesized viral polypeptides were incorporated into intracellular particles. Fourth, newly synthesized viral polypeptides appeared without a longer lag period in extracellular viral particles even before any cy~pathie effects were evident in the cell monolayer.
With the possible exception of the major outer shell protein VP 7, most intracellular viral polypeptides of BRV V 1005 were similar in molecular weight to those of BRV UK and NCDV. This contrasts to the extensive variations in molecular weights reported for intracellular viral polypeptides of rotaviruses from different species (34). However, the apparent molecular weight alone may not be a meaningful criterion to assess the relationship between rotaviral polypeptides of different rotavirus strains.
The similarity and variation in rotaviral structural polypeptides between prototype BRV UK and the second BRV serotype V 1005 defined in this paper is presently-being investigated in our laboratory using biochemical and immunological methods.
